Aminopeptidase inhibitors bestatin and actinonin inhibit cell proliferation of myeloma cells predominantly by intracellular interactions

Cancer Letters

Volumn 182, Issue 2, 2002, Pages 113-119

  Grujić, Mirjana ^a   Renko, Metka ^a  

^a JO EF STEFAN INSTITUTE   (Slovenia)

Author keywords

Actinonin; Bestatin; Cell proliferation; K562; Multidrug resistance associated protein; U937

Indexed keywords

ACTINONIN; AMINOPEPTIDASE; BESTATIN; BUTHIONINE SULFOXIMINE; CELL SURFACE PROTEIN; ENZYME INHIBITOR; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN; VERAPAMIL; VERLUKAST;

ARTICLE; CELL PROLIFERATION; CELL STRAIN K 562; CELL STRAIN U937; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG POTENTIATION; DRUG TRANSPORT; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IC 50; MYELOMA CELL; PRIORITY JOURNAL;

AMINOPEPTIDASES; BUTHIONINE SULFOXIMINE; CELL DIVISION; CELL MEMBRANE; ENZYME INHIBITORS; HUMANS; HYDROXAMIC ACIDS; K562 CELLS; LEUCINE; MULTIPLE MYELOMA; SUBSTRATE SPECIFICITY; U937 CELLS;

EID: 0037190118     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(02)00086-1     Document Type: Article

References (39)

1. Bestatin, an inhibitor of aminopeptidase B, produced by actinomycetes
2. Bestatin, an aminopeptidase inhibitor with a multi-pharmacological function
3. Enhancing effect of ubenimex (Bestatin) on proliferation and differentiation of hematopoietic progenitor cells, and the suppressive effect on proliferation of leukemic cell lines via peptidase regulation
4. Inhibition of tumor invasion and extracellular matrix degradation by ubenimex (bestatin)
5. Expression of aminopeptidase N on human choriocarcinoma cells and cell growth suppression by the inhibition of aminopeptidase N activity
6. Effect of Ubenimex on the proliferation and differentiation of U937 human histiocytic lymphoma cells
7. Aminopeptidase inhibitor ubenimex (Bestatin) inhibits the growth of human choriocarcinoma in nude mice through its direct cytostatic activity
8. Ubenimex activates the E-cadherin-mediated adhesion of a breast cancer cell line YMB-S
9. Induction of apoptosis by ubenimex (Bestatin) in human non-small-cell lung cancer cell lines
10. Inhibitory effects of ubenimex (Bestatin) on the invasion of uterine cervical carcinoma cells and their production and activation of gelatinase
11. Induction of apoptosis by bestatin (ubenimex) in human leukemic cell lines
12. Aminopeptidase inhibitor ubenimex inhibits the growth of leukaemic cell lines and myeloma cells through its cytotoxicity
13. Review of ubenimex (Bestatin): Clinical research
14. Ubenimex in the treatment of acute nonlymphocytic lekemia in adults
15. Adjuvant effect o Ubenimex on a DNA vaccine for HIV-1
16. Properties and specificity of binding sites for the immunomodulator bestatin on the surface of mammalian cells
17. Identification and properties of cell membrane bound leucine aminopeptidase interacting with the potential immunostimulant and chemotherapeutic agent bestatin
18. Inhibition of aminopeptidases N, A and W, a re-evaluation of the actions of bestatin and inhibitors of angiotensin converting enzyme
19. Induction of the membrane alanyl aminopeptidase gene and surface expression in human T-cells by mitogenic activation
20. CD13/N-aminopeptidase is involved in the development of dendritic cells and macrophages from cord blood CD34+ cells
21. Antisense-mediated inhibition of aminopeptidase N (CD13) markedly decreases growth rates of hematopoietic tumour cells
22. Antitumor activity of actinonin in vitro and in vivo
23. Actinonin and antibiotic substance produced by an Actinomycete
24. Production of actinonin, an inhibitor of aminopeptidase M, by actinomycetes
25. +-ATPase-dependent activity of multidrug resistance-associated protein in homoharringtonine-resistant human leukemic K562 cells
26. Increased sensitivity to cis-diamminedichloroplatinum induced apoptosis with mitochondrial DNA depletion
27. Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs
28. Novel mechanisms of drug resistance in leukemia
29. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump
30. Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein
31. The leukotriene LTD4 receptor antagonist MK571 specifically modulates MRP associated multidrug resistance
32. Pharmacology of drugs that alter multidrug resistance in cancer
33. Establishment and characterization of a human histiocytic lymphoma cell line (U-937)
34. Human U937 cell surface peptidase activities: Characterization and degradative effect on tumor necrosis factor-α
35. Purification and characterization of a ubenimex (Bestatin)-sensitive aminopeptidase B-like enzyme from K562 human chronic myeloid leukemia cells
36. The slow, tight binding of bestatin and amastatin to aminopeptidases
37. Kinetics of slow and tight binding inhibitors
38. Aminopeptidase N is a major receptor for the entero-pathogenic coronavirus TGEV
39. Cancer cell-targeted drug delivery utilizing oligopeptide transport activity